Report #2847263

Received Jun 25, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

My child got vaccinated with engerix-B using adult dose; My child got vaccinated with engerix-B using adult dose; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of adult product administered to child in a child patient who received HBV (Engerix B adult) for prophylaxis. On an unknown date, the patient received Engerix B adult. On an unknown date, an unknown time after receiving Engerix B adult, the patient experienced adult product administered to child (Verbatim: My child got vaccinated with engerix-B using adult dose) and overdose (Verbatim: My child got vaccinated with engerix-B using adult dose). The outcome of the adult product administered to child and overdose were not applicable. Additional Information: GSK receipt date: 17-JUN-2025 child got vaccinated with Engerix-B using adult dose, which led to adult product administered to child and overdose.